Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sunil Agarwal currently holds 9,070 shares of Juno Therapeutics, Inc. (JUNO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sunil Agarwal has been a net seller of JUNO stock. They have purchased $0 and sold $4.3M worth of shares.
Sunil Agarwal's most recent insider trade was on May 29, 2024, when they sold 9,070 shares at $0.00 per share.
Sunil Agarwal serves as Executive at Juno Therapeutics, Inc. (JUNO). They have executed 53 insider transactions totaling $4.3M over their tenure at the company.
Sunil Agarwal holds the position of Executive at Juno Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Sunil Agarwal has shown a selling trading pattern, with $0 in total purchases and $4.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sunil Agarwal was on Sep 15, 2021, when they sold $1.5M worth of SANA shares. This transaction involved 58,373 shares at $26.07 per share.
Sunil Agarwal currently owns 9,070 shares of Juno Therapeutics, Inc. (JUNO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sunil Agarwal's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sunil Agarwal has 53 Form 4 filings on record as an insider at Juno Therapeutics, Inc..
Set alerts for Sunil Agarwal and 40,000+ other insiders.